NYSE:NUSNu Skin Enterprises Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Nu Skin Enterprises, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $48.03 +0.64 (+1.35 %) (As of 08/13/2020 04:00 PM ET) Add Compare Share Today's Range$46.79Now: $48.03▼$48.3750-Day Range$37.00MA: $44.08▼$48.0252-Week Range$12.31Now: $48.03▼$48.77Volume403,000 shsAverage Volume883,720 shsMarket Capitalization$2.49 billionP/E Ratio17.92Dividend Yield3.12%Beta1.25 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.Read More Beat the Market (BTM) Rank™ 2.1 Analyst's Opinion Consensus RatingNu Skin Enterprises has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on 3 buy ratings, 3 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $48.83, Nu Skin Enterprises has a potential upside of 1.7% from its current price of $48.03.Amount of Analyst CoverageNu Skin Enterprises has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.6 Community Rank Outperform VotesNu Skin Enterprises has received 495 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNu Skin Enterprises has received 474 “underperform” votes. (Add your “underperform” vote.)Community SentimentNu Skin Enterprises has received 51.08% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote “Outperform” if you believe NUS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend YieldNu Skin Enterprises pays a meaningful dividend of 3.12%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNu Skin Enterprises has only been increasing its dividend for 1 years.Dividend CoverageThe dividend payout ratio of Nu Skin Enterprises is 48.39%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 49.34% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nu Skin Enterprises insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,399,150.00 in company stock.Percentage Held by InsidersOnly 3.40% of the stock of Nu Skin Enterprises is held by insiders.Percentage Held by Institutions73.06% of the stock of Nu Skin Enterprises is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Nu Skin Enterprises are expected to decrease by -2.88% in the coming year, from $3.13 to $3.04 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nu Skin Enterprises is 17.92, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 17.46.Price to Earnings Ratio vs. SectorThe P/E ratio of Nu Skin Enterprises is 17.92, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 47.95.Price to Earnings Growth RatioNu Skin Enterprises has a PEG Ratio of 2.67. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioNu Skin Enterprises has a P/B Ratio of 3.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.1Community Rank: 2.6Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.77 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Drugs, proprietaries, & sundries Sub-IndustryPersonal Products SectorConsumer Staples Current SymbolNYSE:NUS Previous Symbol CUSIP67018T10 CIK1021561 Webwww.nuskinenterprises.com Phone801-345-1000Debt Debt-to-Equity Ratio0.53 Current Ratio1.62 Quick Ratio1.08Price-To-Earnings Trailing P/E Ratio17.92 Forward P/E Ratio15.35 P/E Growth2.67 Sales & Book Value Annual Sales$2.42 billion Price / Sales1.03 Cash Flow$4.63 per share Price / Cash Flow10.38 Book Value$15.74 per share Price / Book3.05Profitability EPS (Most Recent Fiscal Year)$3.10 Net Income$173.55 million Net Margins6.33% Return on Equity17.60% Return on Assets8.28%Miscellaneous Employees4,900 Outstanding Shares51,899,000Market Cap$2.49 billion Next Earnings Date11/3/2020 (Estimated) OptionableOptionable $48.03 +0.64 (+1.35 %) (As of 08/13/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive NUS News and Ratings via Email Sign-up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter. Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions How has Nu Skin Enterprises' stock price been impacted by Coronavirus? Nu Skin Enterprises' stock was trading at $21.06 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NUS stock has increased by 128.1% and is now trading at $48.03. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Nu Skin Enterprises? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Nu Skin Enterprises. When is Nu Skin Enterprises' next earnings date? Nu Skin Enterprises is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020. View our earnings forecast for Nu Skin Enterprises. How were Nu Skin Enterprises' earnings last quarter? Nu Skin Enterprises, Inc. (NYSE:NUS) announced its earnings results on Wednesday, August, 5th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.67 by $0.14. The business earned $612.37 million during the quarter, compared to analyst estimates of $606.02 million. Nu Skin Enterprises had a net margin of 6.33% and a return on equity of 17.60%. View Nu Skin Enterprises' earnings history. How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises? Nu Skin Enterprises announced a quarterly dividend on Wednesday, August 5th. Shareholders of record on Friday, August 28th will be paid a dividend of $0.375 per share on Wednesday, September 9th. This represents a $1.50 dividend on an annualized basis and a dividend yield of 3.12%. The ex-dividend date of this dividend is Thursday, August 27th. View Nu Skin Enterprises' dividend history. What guidance has Nu Skin Enterprises issued on next quarter's earnings? Nu Skin Enterprises updated its FY20 earnings guidance on Wednesday, August, 5th. The company provided EPS guidance of $2.85-3.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.45. The company issued revenue guidance of $2.37-2.45 billion, compared to the consensus revenue estimate of $2.32 billion. What price target have analysts set for NUS? 7 brokers have issued 12 month price targets for Nu Skin Enterprises' stock. Their forecasts range from $30.00 to $61.00. On average, they anticipate Nu Skin Enterprises' stock price to reach $48.83 in the next year. This suggests a possible upside of 1.7% from the stock's current price. View analysts' price targets for Nu Skin Enterprises. Has Nu Skin Enterprises been receiving favorable news coverage? Headlines about NUS stock have been trending negative recently, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Nu Skin Enterprises earned a news sentiment score of -2.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about Nu Skin Enterprises. Are investors shorting Nu Skin Enterprises? Nu Skin Enterprises saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 1,860,000 shares, a drop of 23.8% from the June 15th total of 2,440,000 shares. Based on an average daily volume of 888,100 shares, the days-to-cover ratio is currently 2.1 days. Currently, 3.8% of the company's stock are short sold. View Nu Skin Enterprises' Short Interest. Who are some of Nu Skin Enterprises' key competitors? Some companies that are related to Nu Skin Enterprises include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Medifast (MED), Prestige Consumer Healthcare (PBH), USANA Health Sciences (USNA), Inter Parfums (IPAR), Revlon (REV), Nature's Sunshine Products (NATR) and Veru (VERU). View all competitors. What other stocks do shareholders of Nu Skin Enterprises own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), Marathon Petroleum (MPC), Herbalife Nutrition (HLF), Las Vegas Sands (LVS), Netflix (NFLX), Nike (NKE), NVIDIA (NVDA), Baidu (BIDU) and Gilead Sciences (GILD). Who are Nu Skin Enterprises' key executives? Nu Skin Enterprises' management team includes the following people: Mr. Steven J. Lund, Exec. Chairman (Age 66)Mr. Ritch N. Wood, CEO & Director (Age 53)Mr. Ryan S. Napierski, Pres (Age 45)Mr. Mark H. Lawrence, Exec. VP & CFO (Age 49)Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 66) What is Nu Skin Enterprises' stock symbol? Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS." Who are Nu Skin Enterprises' major shareholders? Nu Skin Enterprises' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Bank of New York Mellon Corp (1.76%), Ensign Peak Advisors Inc (1.37%), First Trust Advisors LP (0.97%), Goldman Sachs Group Inc. (0.92%), ProShare Advisors LLC (0.91%) and Wasatch Advisors Inc. (0.64%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Foulis Greg, Joseph Y Chang and Ritch N Wood. View institutional ownership trends for Nu Skin Enterprises. Which institutional investors are selling Nu Skin Enterprises stock? NUS stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., UBS Group AG, Bank of Nova Scotia, Federated Hermes Inc., Barclays PLC, Bank of New York Mellon Corp, Seizert Capital Partners LLC, and Prescott Group Capital Management L.L.C.. View insider buying and selling activity for Nu Skin Enterprises. Which institutional investors are buying Nu Skin Enterprises stock? NUS stock was bought by a variety of institutional investors in the last quarter, including Ensign Peak Advisors Inc, First Trust Advisors LP, ProShare Advisors LLC, Empowered Funds LLC, MUFG Securities EMEA plc, WINTON GROUP Ltd, Skandinaviska Enskilda Banken AB publ , and Mackay Shields LLC. View insider buying and selling activity for Nu Skin Enterprises. How do I buy shares of Nu Skin Enterprises? Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Nu Skin Enterprises' stock price today? One share of NUS stock can currently be purchased for approximately $48.03. How big of a company is Nu Skin Enterprises? Nu Skin Enterprises has a market capitalization of $2.49 billion and generates $2.42 billion in revenue each year. The company earns $173.55 million in net income (profit) each year or $3.10 on an earnings per share basis. Nu Skin Enterprises employs 4,900 workers across the globe. What is Nu Skin Enterprises' official website? The official website for Nu Skin Enterprises is www.nuskinenterprises.com. How can I contact Nu Skin Enterprises? Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected] This page was last updated on 8/13/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
